2221 - 2230 of 7915 Results
Title
Year
- Poster Session2022OPENTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 0
-
OPENTitle: POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USAJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734609Citation Count: 2
-
RESTRICTEDTitle: Profiles of women in science: Malú Gámez Tansey, Norman and Susan Fixel Professor of Neuroscience and Neurology, Co‐Director of the Center for Translational Research in Neurodegenerative Disease and Director of the Parkinson's Foundation Research Center of Excellence, University of Florida College of MedicineJournal Name: European Journal of NeurosciencePublisher: WileyVol: 55Issue #: 2Start Page: 350End Page: 353Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15578Citation Count: 0
-
RESTRICTEDTitle: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100161End Page: 100161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100161Citation Count: 7
-
OPENTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 1
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 36
-
RESTRICTEDTitle: The many genomes of Parkinson's diseaseJournal Name: Microbiome in Neurological DiseasePublisher: ElsevierVol:Issue #:Start Page: 59End Page: 80Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.07.007Citation Count: 2
-
RESTRICTEDTitle: The neuropsychiatry of Parkinson's disease: advances and challengesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 89End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00330-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800169Citation Count: 151
-
RESTRICTEDTitle: Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 1Start Page: 207End Page: 237Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1124/pharmrev.120.000133Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/74/1/207.full.pdfCitation Count: 39
-
RESTRICTEDTitle: Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disordersJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 229Issue #:Start Page: 107937End Page: 107937Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107937Citation Count: 34